Cipla signs pact with Taiwan drug firm
Cipla has announced an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals to market clobetasol propionate ophthalmic suspension 0.05% (APP13007) across 11 countries, including India. It is used to treat post-op inflammation and pain following ocular surgery.
Stay informed with the latest business news, updates on bank holidays and public holidays.
Stay informed with the latest business news, updates on bank holidays and public holidays.
Popular from Business
- Is a US recession coming? 7 charts that show the plight of the American economy
- Elon Musk’s Starlink may offer 80-90 times more than capacity of rivals Reliance Jio-SES, Eutelsat OneWeb
- Sensex rally leaves investors wealthier by Rs 8.67 lakh crore over 2 days! Top 8 reasons stock markets are rising
- Noel Tata, Ratan Tata’s half sisters Shireen and Deanna Jejeebhoy join board of Ratan Tata Endowment Trust
- Will Bitcoin price crash to $20,000? Peter Schiff makes big prediction if Nasdaq enters bear market phase
end of article
Trending Stories
- Noel Tata, Ratan Tata’s half sisters Shireen and Deanna Jejeebhoy join board of Ratan Tata Endowment Trust
- Stock market today: BSE Sensex opens over 400 points up; Nifty50 above 22,600
- Top stocks to buy today: Stock recommendations for March 18, 2025
- Will Bitcoin price crash to $20,000? Peter Schiff makes big prediction if Nasdaq enters bear market phase
- Meet Srikanth Bolla, Shark Tank India’s new judge, who is visually impaired - know his inspirational success story
- Top stocks to buy: Stock recommendations for the week starting March 17, 2025
- Stock market today: BSE Sensex opens over 300 points up; Nifty50 above 22,500
Visual Stories
- 8 Chanakya Sutras to lead students to success through intelligent effort
- 8 reasons why studying too hard is ruining your test scores
- 8 Rabindranath Tagore Poems to Help Students Cope with Hardships and Change
- 8 most effective tips to score high in CUET 2025
- 8 powerful strategies to cover vast syllabus at the last minute
TOP TRENDS
UP NEXT
Start a Conversation
Post comment